The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
Open accessAbstract
Background Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the effects of retinal gene therapy with an adeno-associated viral (AAV) vector encoding REP1 (AAV.REP1) in patients with this disease.Methods In a multicentre clinical trial, six male patients (aged 35-63 years) with choroideremia were administered AAV.REP1 (0·6-1·0×10(10) genome particles, subfoveal injection). Visual function tests included best corrected visual acuity, microperimetry, and retinal sensitivity tests for comparison of baseline values with 6 months after surgery. This study is registered with ClinicalTrials.gov, number NCT01461213.Findings Despite undergoing retinal detachment, which normally reduces vision, two patients with advanced choroideremia who had low baseline best corrected visual acuity gained 21 letters and 11 letters (more than two and four lines of vision). Four other patients with near normal best corrected visual acuity at baseline recovered to within one to three letters. Mean gain in visual acuity overall was 3·8 letters (SE 4·1). Maximal sensitivity measured with dark-adapted microperimetry increased in the treated eyes from 23·0 dB (SE 1·1) at baseline to 25·3 dB (1·3) after treatment (increase 2·3 dB [95% CI 0·8-3·8]). In all patients, over the 6 months, the increase in retinal sensitivity in the treated eyes (mean 1·7 [SE 1·0]) was correlated with the vector dose administered per mm(2) of surviving retina (r=0·82, p=0·04). By contrast, small non-significant reductions (p>0·05) were noted in the control eyes in both maximal sensitivity (-0·8 dB [1·5]) and mean sensitivity (-1·6 dB [0·9]). One patient in whom the vector was not administered to the fovea re-established variable eccentric fixation that included the ectopic island of surviving retinal pigment epithelium that had been exposed to vector.Interpretation The initial results of this retinal gene therapy trial are consistent with improved rod and cone function that overcome any negative effects of retinal detachment. These findings lend support to further assessment of gene therapy in the treatment of choroideremia and other diseases, such as age-related macular degeneration, for which intervention should ideally be applied before the onset of retinal thinning.Funding UK Department of Health and Wellcome Trust.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite a 28-day oral corticosteroid therapy started 2 days before the first IVT, a regimen similar to that provided in several other clinical studies using IVT or sub-retinal AAV-based gene therapies,41–45 70.7% of lenadogene nolparvovec-treated eyes developed some degree of intraocular inflammation versus 10.2% of placebo-treated eyes.”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a consequence, wild-type AAV-based gene therapies for ophthalmologic indications generally require relatively high doses and/or administration via subretinal injection, an invasive surgical procedure that requires detachment of photoreceptors from the RPE and reportedly results in transduction of <5% of the retinal surface. 25 – 27”
From Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies (2024) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although adeno-associated viral (AAV) vector-mediated retinal gene therapies have demonstrated efficacy”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, a recent phase I trial for choroideremia showed promising signs of efficacy.15”
From Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates (2015) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Adeno-associated virus has been successful in clinical gene therapy trials for Leber's congenital amaurosis, hemophilia, familial lipoprotein lipase deficiency, and choroideremia.8–15,26,27,60,61”
From Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates (2015) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“A different approach to subretinal injection is a 'two-step ' injection with initiation of a small 'pre-bleb ' using balanced saline solution (BSS) followed by slow propagation of the bleb using the viral vector (MacLaren et al., 2014). A considerable advantage of two-step injection is that it allows bleb propagation at a lower injection pressure (Scruggs et al., 2022).”
From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as MacLaren et al., 2014
In the citing paper
“Significant inflammation was also observed at 1 × 1011 vg in clinical trials for choroideremia.90,102”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [102]
In the citing paper
“Injection protocols dating to 2014 (30, 31) called for a 2-step procedure, which largely avoids causing a break in Bruch's membrane but does not completely eliminate the risk (20, 32).”
From Subretinal therapy: technological solutions to surgical and immunological challenges (2022) · cites this paper as [30]
In the citing paper
“while subretinal viral gene therapy has a favourable safety profile [300]”
From Bruch’s Membrane: A Key Consideration with Complement-Based Therapies for Age-Related Macular Degeneration (2023) · cites this paper as [300]
In the citing paper
“A phase I/II clinical trial of subretinal gene therapy using an AAV2 vector to deliver human REP1 to the outer retina has shown sustained preservation or improvement of visual acuity over 2 to 5 years in patients with advanced disease [MacLaren 2014, Xue 2018].”
From Correcting visual loss by genetics and prosthetics (2020) · cites this paper as MacLaren 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70039-4 · Cited by 681
Self-citationJacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Świder, M., Iwabe, S., Román, A. J., Olivares, M. B., Schwartz, S., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 441
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002865 · Cited by 395
Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase
Seabra, M. C., Brown, M. S., & Goldstein, J. L. (1993) · Science · doi:10.1126/science.8380507 · Cited by 337
Self-citationCloning of a gene that is rearranged in patients with choroideraemia
Cremers, F. P. M., van de Pol, D. J. R., van Kerkhoff, L. P. M., Wieringa, B., & Ropers, H.-H. (1990) · Nature · doi:10.1038/347674a0 · Cited by 333
Self-citationLoeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016942 · Cited by 279
Cited by
Sorted by citations
Items 501–600 of 795
Basic and Clinical Application of Adeno-Associated Virus–Mediated Genome Editing
He, X., Xie, H., Liu, X., & Gu, F. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.190 · Cited by 7
Dubis, A. M., Lim, W. S., Jolly, J. K., Toms, M., MacLaren, R. E., Webster, A. R., & Moosajee, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020232 · Cited by 9
Self-citationForgham, H., Liu, L., Zhu, J., Javed, I., Cai, W., Qiao, R., & Davis, T. P. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215172 · Cited by 9
Choroideremia: melanopsin‐mediated postillumination pupil relaxation is abnormally slow
Ba‐Ali, S., Christensen, S. K., Sander, B., Rosenberg, T., Larsen, M., & Lund‐Andersen, H. (2017) · Acta Ophthalmologica · doi:10.1111/aos.13394 · Cited by 9
The clinical implications of molecular monitoring and analyses of inherited retinal diseases
Chacon-Camacho, O. F., García‐Montaño, L. A., & Zenteno, J. C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1384314 · Cited by 8
Vector Shedding and Immunogenicity Sampling for Retinal Gene Therapy
Barnard, A. R., Rudenko, A., & MacLaren, R. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_27 · Cited by 9
Self-citationDegenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated
Kamar, S., Howlett, M. H. C., Klooster, J., de Graaff, W., Csikós, T., Rabelink, M. J. W. E., Hoeben, R. C., & Kamermans, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020522 · Cited by 9
Stanga, P. E., Tsamis, E., Sisó-Fuertes, I., Dorn, J. D., Merlini, F., Fisher, A., Crawford, F. I. J., Kasbia, S., Papayannis, A., Baseler, H. A., et al. (2021) · European Journal of Ophthalmology · doi:10.1177/11206721211000680 · Cited by 9
Ganne, P., Damagatla, M., & Naidu, N. K. (2021) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo_34_21 · Cited by 9
Fajardo‐Serrano, A., Rico, A. J., Roda, E., Honrubia, A., Arrieta, S., Ariznabarreta, G., Chocarro, J., Lorenzo-Ramos, E., Pejenaute, Á., Vázquez, A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10040746 · Cited by 9
Subretinal and Intravitreal Retinal Injections in Monkeys
Dauletbekov, D., Bartz‐Schmidt, K. U., & Fischer, M. D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_18 · Cited by 9
Gene therapy – Principles and Applications
Pathak, S. (2022) · Global Journal of Transfusion Medicine · doi:10.4103/gjtm.gjtm_87_21 · Cited by 9
Semiautomated Subretinal Fluid Injection Method Using Viscous Fluid Injection Mode
Kwon, H. J., Kwon, O. W., & Song, W. K. (2018) · Retina · doi:10.1097/iae.0000000000002025 · Cited by 9
Halioua-Haubold, C.-L., Jolly, J. K., Smith, J. A., Pinedo‐Villanueva, R., Brindley, D. A., & MacLaren, R. E. (2019) · Eye · doi:10.1038/s41433-019-0492-1 · Cited by 9
Self-citationEngineered AAV vectors for improved central nervous system gene delivery
Kotterman, M. A., & Schaffer, D. V. (2015) · Neurogenesis · doi:10.1080/23262133.2015.1122700 · Cited by 9
Hinsch, V. G., Boye, S. L., & Boye, S. E. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.252 · Cited by 10
Targeting the Eye: RNA-Based Therapies, Interferences, and Delivery Strategies
Abdel‐Raziq, M. S., Zhong, C., Hassan, F. E., & Li, S. K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101326 · Cited by 11
Pars Plana Vitrectomy in Inherited Retinal Diseases: A Comprehensive Review of the Literature
Iovino, C., Rosolia, A., Damiano, L., Iodice, C. M., Iorio, V. D., Testa, F., & Simonelli, F. (2023) · Life · doi:10.3390/life13061241 · Cited by 8
Genetics of retinitis pigmentosa and other hereditary retinal disorders in Western Switzerland
Conti, G. M., Vaclavik, V., Rivolta, C., Escher, P., Schorderet, D. F., Munier, F. L., & Tran, H. V. (2023) · Ophthalmic Research · doi:10.1159/000536036 · Cited by 8
Scanga, H. L., & Nischal, K. K. (2014) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2014.03.005 · Cited by 9
Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia
Shimizu, K., Oishi, A., Oishi, M., Ogino, K., Morooka, S., Sugahara, M., Gotoh, N., & Yoshimura, N. (2015) · Case Reports in Ophthalmology · doi:10.1159/000437348 · Cited by 8
Recent Innovations in Medical and Surgical Retina
Bhagat, N., & Zarbin, M. A. (2015) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000121 · Cited by 8
Nanoengineered biomaterials for retinal repair
Patel, B. B., Sharma, A. D., Mammadova, N., Sandquist, E. J., Uz, M., Mallapragada, S. K., & Sakaguchi, D. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813355-2.00010-7 · Cited by 8
Eblimit, A., Makia, M. S., Strayve, D., Crane, R., Conley, S. M., Sinha, T., Acharya, G. S., Al‐Ubaidi, M. R., & Naash, M. I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091510 · Cited by 8
Precision Medicine Trials in Retinal Degenerations
Levi, S. R., Ryu, J., Liu, P., & Tsang, S. H. (2021) · Annual Review of Vision Science · doi:10.1146/annurev-vision-100419-111701 · Cited by 8
Bilateral visual acuity decline in males with choroideremia: a pooled, cross-sectional meta-analysis
Bozkaya, D., Zou, H., Lu, C., Tsao, N., & Lam, B. L. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02250-z · Cited by 8
Xu, P., Jiang, Y. Y., & Morgan, J. I. W. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.10.36 · Cited by 8
Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres
Crane, R., Makia, M. S., Zeibak, S., Tebbe, L., Ikelle, L., Woods, C. R., Conley, S. M., Acharya, G. S., Naash, M. I., & Al‐Ubaidi, M. R. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102222 · Cited by 9
Curing blindness: Vision quest
Lok, C. (2014) · Nature · doi:10.1038/513160a · Cited by 8
A non‐surgical method for subretinal delivery by trans‐scleral microneedle injection
Hejri, A., Chrenek, M. A., Goehring, N. T., Bowland, I. I., Noel, R. K., Yan, J., Nickerson, J. M., & Prausnitz, M. R. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10755 · Cited by 8
AlEissa, M. M., Alhawsawi, A. A., Alonazi, R. H., Magharbil, E., Aljahdali, A., ALBalawi, H. B., Alali, N. M., Hameed, S., Abu‐Amero, K. K., & Magliyah, M. (2025) · Genes · doi:10.3390/genes16070847 · Cited by 7
Du, W., Li, J., Tang, X., Yu, W., & Zhao, M. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231199069 · Cited by 7
Gene therapy for retinal diseases: From genetics to treatment
Khaparde, A., Mathias, G. P., Poornachandra, B., Thirumalesh, M. B., Shetty, R., & Ghosh, A. (2024) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2902_23 · Cited by 8
Munegowda, M. A., & Hu, J. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0023-0 · Cited by 7
Artificial vision: principles and prospects
Gilhooley, M. J., & Acheson, J. F. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000412 · Cited by 7
The Degeneration and Apoptosis Patterns of Cone Photoreceptors in rd11 Mice
Zhang, H., Li, X., Dai, X., Han, J., Zhang, Y., Qi, Y., He, Y., Liu, Y., Chang, B., & Pang, J. (2017) · Journal of Ophthalmology · doi:10.1155/2017/9721362 · Cited by 7
Novel non‐contiguous exon duplication in choroideremia
Edwards, T. L., Williams, J. P., Patrício, M. I., Simunovic, M. P., Shanks, M. E., Clouston, P., & MacLaren, R. E. (2017) · Clinical Genetics · doi:10.1111/cge.13021 · Cited by 7
Self-citationCurrent Concepts and Emerging Gene Therapies for Inherited Retinal Diseases
Gregori, N. Z., Hussain, R. M., Kay, C. N., Lam, B. L., Dermer, H., & Davis, J. L. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000259 · Cited by 7
Iuliano, L., Fogliato, G., Corbelli, E., Bandello, F. M., & Codenotti, M. (2020) · Eye · doi:10.1038/s41433-020-01188-0 · Cited by 7
Optical coherence tomography in children with inherited retinal disease
Jolly, J. K., Rodda, B. M., Edwards, T. L., Ayton, L. N., & Ruddle, J. B. (2024) · Clinical and Experimental Optometry · doi:10.1080/08164622.2023.2294807 · Cited by 7
Gene Therapy for Retinal Disease: What Lies Ahead
MacLaren, R. E. (2015) · Ophthalmologica · doi:10.1159/000438872 · Cited by 7
Self-citationAttenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
Cho, G. Y., Bolo, K. A., Park, K. S., Sengillo, J. D., & Tsang, S. H. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0377-1 · Cited by 8
A detailed in vivo analysis of the retinal nerve fibre layer in choroideremia
Fu, D. J., Xue, K., Jolly, J. K., & MacLaren, R. E. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13973 · Cited by 7
Self-citationA Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1
Wood, S., McClements, M. E., de la Cámara, C. M.-F., Patrício, M. I., Uggenti, C., Sekaran, S., Barnard, A. R., Manson, F. D. C., & MacLaren, R. E. (2019) · Human Gene Therapy Methods · doi:10.1089/hgtb.2018.267 · Cited by 7
Self-citationHayashi, T., Kameya, S., Mizobuchi, K., Kubota, D., Kikuchi, S., Yoshitake, K., Mizota, A., Murakami, A., Iwata, T., & Nakano, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-72623-1 · Cited by 7
Genetic analysis of choroideremia families in the A ustralian population
McLaren, T. L., Roach, J. N. D., Montgomery, H., Hoffmann, L., Kap, C., & Lamey, T. M. (2015) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12542 · Cited by 7
Kwon, H.-J., Qing, K., Ponnazhagan, S., Wang, X.-S., Markusic, D. M., Gupte, S., Boye, S. E., & Srivastava, A. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.018 · Cited by 6
Gene therapy for the heart: encapsulated viruses to the rescue
Deshetty, U. M., Sil, S., & Buch, S. J. (2024) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.70 · Cited by 7
Morphometric evaluation of cerebellar structures in late monocular blindness
Özen, Ö., & Aslan, F. (2020) · International Ophthalmology · doi:10.1007/s10792-020-01629-5 · Cited by 6
Fernandes, S., Diogo, J., & Coroadinha, A. S. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230331111336 · Cited by 6
Oxidative and Endoplasmic Reticulum Stress Represent Novel Therapeutic Targets for Choroideremia
Sarkar, H., Lahne, M., Nair, N., & Moosajee, M. (2023) · Antioxidants · doi:10.3390/antiox12091694 · Cited by 6
Tang, M., Zhong, L., Rong, H., Li, K., Ye, M., Peng, J., & Ge, J. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109931 · Cited by 6
Phenotypic and Genetic Spectrum in 309 Consecutive Pediatric Patients with Inherited Retinal Disease
Priglinger, C., Gerhardt, M. J., Priglinger, S. G., Schaumberger, M. M., Neuhann, T., Bolz, H. J., Mehraein, Y., & Rudolph, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212259 · Cited by 7
Chen, J.-H., Zhan, L.-J., Lv, C.-M., Teng, J.-B., & Cao, C. (2025) · Current Medical Science · doi:10.1007/s11596-025-00084-6 · Cited by 7
Gentherapie als Behandlungskonzept für erbliche Netzhauterkrankungen
Bellingrath, J.-S., & Fischer, M. D. (2015) · Der Ophthalmologe · doi:10.1007/s00347-015-0121-8 · Cited by 6
Elbaha, S., Hadi, A. M. A., & Abouhussein, M. A. (2019) · Journal of Ophthalmology · doi:10.1155/2019/6274209 · Cited by 6
AAV-Mediated Gene Delivery to Foveal Cones
Bertin, S., Brazhnikova, E., Jaillard, C., Sahel, J., & Dalkara, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0755-8_6 · Cited by 6
Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
Patel, D. D., Marsic, D., Periasamy, R., Zolotukhin, S., & Lipinski, D. M. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.8.28 · Cited by 6
Restoration of synaptic function in sight for degenerative retinal disease
Schubert, T., & Wissinger, B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82577 · Cited by 6
Outcomes following cataract surgery in choroideremia
Edwards, T. L., Groppe, M., & MacLaren, R. E. (2015) · Eye · doi:10.1038/eye.2014.326 · Cited by 6
Self-citationAetiological Diagnosis of Child Deafness: CODEPEH Recommendations
Núñez-Batalla, F., Jáudenes-Casaubón, C., Canet, J. M. S., Vivanco-Allende, A., Zubicaray-Ugarteche, J., & Farpón, R. C. (2017) · Acta Otorrinolaringologica (English Edition) · doi:10.1016/j.otoeng.2016.05.002 · Cited by 6
CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1
Sengillo, J. D., Lee, W., Bakhoum, M. F., Cho, G. Y., Chiang, J., & Tsang, S. H. (2017) · Retinal Cases & Brief Reports · doi:10.1097/icb.0000000000000647 · Cited by 6
Multimodal imaging of the carriers of choroideremia and X-linked retinitis pigmentosa
Yang, J., Wang, L., Yu, R., Hu, L., Gong, X., Chen, L., Hu, B., Li, X., & Li, Z. (2018) · International Journal of Ophthalmology · doi:10.18240/ijo.2018.10.23 · Cited by 6
Jimenez, J. E., Nourbakhsh, A., Colbert, B., Mittal, R., Yan, D. L. S., Green, C. L., Nisenbaum, E. S., Liu, C., Bencie, N., Rudman, J. R., et al. (2020) · Gene · doi:10.1016/j.gene.2020.144677 · Cited by 6
Kim, C. H., Oliver, C., Dar, H. Y., Drissi, H., & Presciutti, S. M. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.12.009 · Cited by 6
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Han, R. C., Fry, L. E., Kantor, A., McClements, M. E., Xue, K., & MacLaren, R. E. (2021) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2021.1882300 · Cited by 6
Self-citationMacular Rod Function in Retinitis Pigmentosa Measured With Scotopic Microperimetry
Krishnan, A. K., Román, A. J., Świder, M., Jacobson, S. G., & Cideciyan, A. V. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.11.3 · Cited by 6
An optometrist’s guide to the top candidate inherited retinal diseases for gene therapy
O’Hare, F., Edwards, T. L., Hu, M. L., Hickey, D. G., Britten‐Jones, A. C., Wang, J.-H., Liu, Z., & Ayton, L. N. (2021) · Clinical and Experimental Optometry · doi:10.1080/08164622.2021.1878851 · Cited by 6
Intravitreally Injected Fluid Dispersion: Importance of Injection Technique
Willekens, K., Reyns, G., Diricx, M., Vanhove, M., Noppen, B., Coudyzer, W., Ni, Y., Feyen, J. H. M., & Stalmans, P. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20543 · Cited by 6
Correcting visual loss by genetics and prosthetics
Xue, K., & MacLaren, R. E. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.03.003 · Cited by 5
Self-citationFu, D. J., Lipkova, V., Liefers, B. J., Glinton, S. L., Faes, L., McKeown, A. S., Scheibler, L., Pontikos, N., Patel, P. J., Zhang, G., et al. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00798-7 · Cited by 6
Karaosmanoğlu, B., İmren, G., Ütine, E., Şekeroğlu, H. T., & Taşkıran, E. Z. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.109833 · Cited by 5
Updates on protein-prenylation and associated inherited retinopathies
Ashok, S., & Rao, S. R. (2024) · Frontiers in Ophthalmology · doi:10.3389/fopht.2024.1410874 · Cited by 6
DAPT mediates atoh1 expression to induce hair cell-like cells.
Ren, H., Guo, W., Liu, W., Gao, W., Xie, D., Yin, T., Yang, S., & Ren, J. (2016) · PubMed Central · Cited by 5
Small Molecule-Based Inducible Gene Therapies for Retinal Degeneration
Datta, S., Peng, H., & Hulleman, J. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-27378-1_11 · Cited by 5
Viral Vector Technologies and Strategies: Improving on Nature
Croze, R. H., Kotterman, M. A., Burns, C. H., Schmitt, C. E., Quezada, M., Schaffer, D. V., Kirn, D. H., & Francis, P. J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000361 · Cited by 5
Using Goldmann Visual Field Volume to Track Disease Progression in Choroideremia
DeLuca, A. P., Whitmore, S. S., Tatro, N. J., Andorf, J. L., Faga, B. P., Faga, L. A., Collins, M. M., Luse, M. A., Fenner, B. J., Stone, E. M., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100397 · Cited by 5
AAV Vector-Based Gene Therapy, Progress and Current Challenges
Kuranda, K., & Mingozzi, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-53457-2_5 · Cited by 5
Harnessing the Power of Genetic Engineering for Patients With Mitochondrial Eye Diseases
Yu‐Wai‐Man, P. (2017) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000476 · Cited by 5
Gene Therapy for Inherited Retinopathies: Update on Development Progress
Sun, S. Y., & Montezuma, S. R. (2018) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126418783934 · Cited by 5
McLaren, T. L., Roach, J. N. D., Thompson, J. A., Chen, F. K., Mackey, D. A., Hoffmann, L., Urwin, I. R., & Lamey, T. M. (2020) · Human Genome Variation · doi:10.1038/s41439-020-00122-w · Cited by 5
Challenges in development and authorisation of gene therapy products
Алексеевич, С. А., Авдеева, Ж. И., Витальевич, Г. Д., Khantimirova, L. M., Guseva, S. G., & Меркулов, В. А. (2022) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2022-22-1-6-22 · Cited by 5
Greig, L. C., Gutierrez, K. G., Oh, J. K., Levi, S. R., Korot, E., Tsang, S. H., & Mahajan, V. B. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101543 · Cited by 6
Gene Therapy Using Efficient Direct Lineage Reprogramming Technology for Neurological Diseases
Chang, Y., Lee, S., Kim, J., Kim, C., Shim, H. S., Lee, S. E., Park, H. J., Kim, J., Lee, S., Lee, Y. K., et al. (2023) · Nanomaterials · doi:10.3390/nano13101680 · Cited by 5
Prospective therapeutic approaches in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
Cabrera-Pérez, R., Torres‐Torronteras, J., Vila‐Julià, F., Ortega, F. J., Cámara, Y., Barquinero, J., & Martí, R. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1090307 · Cited by 6
Preclinical study of rAAV2-sTRAIL: pharmaceutical efficacy, biodistribution and safety in animals
Ru, Q., Li, W., Wang, X., Zhang, S., Chen, L., Zhang, Y., Ge, Y. C., Zu, Y., Liu, Y., & Zheng, D. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.12 · Cited by 5
Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene
Gray, J. M., Orlans, H. O., Shanks, M. E., Clouston, P., & MacLaren, R. E. (2018) · Ophthalmic Genetics · doi:10.1080/13816810.2018.1474369 · Cited by 5
Self-citationLoozen, L. D., Kruyt, M. C., Vandersteen, A., Kragten, A. H. M., Croes, M., Öner, F. C., & Alblas, J. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0032 · Cited by 5
Quantification of RPE Changes in Choroideremia Using a Photoshop-Based Method
Zhai, Y., Xu, M., Dimopoulos, I. S., Birch, D. G., Bernstein, P. S., Holt, J., Kirn, D. H., Francis, P. J., & MacDonald, I. M. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.7.21 · Cited by 5
Choroideremia: Toward Regulatory Approval of Retinal Gene TherapyPreprint
Yusuf, I. H., & MacLaren, R. E. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041279 · Cited by 5
Self-citationRetinal Patterns and the Role of Autofluorescence in Choroideremia
Poli, F. E., MacLaren, R. E., & Cehajic‐Kapetanovic, J. (2024) · Genes · doi:10.3390/genes15111471 · Cited by 4
Self-citationGene therapy for choroideremia: progress, potential and pitfalls
Elsayed, M. E. A. A., Cehajic‐Kapetanovic, J., & MacLaren, R. E. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2459850 · Cited by 4
Self-citationCross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy
Ramachandran, S. S., Ardinger, J., Bu, J., Ramos, M., Guo, L., Ghosh, D., Hossain, M., Chou, S.-C., Chen, Y., Wischhof, E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185001 · Cited by 6
Retinal BMI1 Expression Preserves Photoreceptors in Sodium-Iodate-Induced Oxidative Stress Models
Lu, Z., Liu, S., Morales, M. G., Whitlock, A., Ramkumar, R., & Ramkumar, H. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125907 · Cited by 5
mGem: AAV, from almost a virus to an awesome vector—or is it?
Srivastava, A. (2026) · mBio · doi:10.1128/mbio.02957-25 · Cited by 5
Skorczyk‐Werner, A., Wawrocka, A., Kochalska, N., & Krawczynski, M. R. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0965-5 · Cited by 4
Atypical choroideremia presenting with early‐onset macular atrophy
Kontos, G., Kwan, J., Xue, K., Patrício, M. I., Clouston, P., Packham, E. R., MacLaren, R. E., & Downes, S. M. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14025 · Cited by 4
Self-citationSynonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia
da Palma, M. M., Motta, F. L., Gomes, C. P., Salles, M. V., Pesquero, J. B., & Sallum, J. M. F. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.2.38 · Cited by 4
Improving retinal vascular endothelial cell tropism through rational rAAV capsid design
Periasamy, R., Patel, D. D., Boye, S. L., Boye, S. L., & Lipinski, D. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285370 · Cited by 5
How Advanced are Nanocarriers for Effective Subretinal Injection?
Guan, J.-X., Wang, Y.-L., & Wang, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s479327 · Cited by 4
Metadata
- Authors
- MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., Lotery, A. J., Downes, S. M., Webster, A. R., & Seabra, M. C.
- Affiliations
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- University of Oxford (GB)
- NIHR Oxford Biomedical Research Centre (GB)
- Imperial College London (GB)
- Nationwide Children's Hospital (US)
- The Ohio State University Wexner Medical Center (US)
- Radboud University Nijmegen (NL)
- Manchester Academic Health Science Centre (GB)
- University of Southampton (GB)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 383
- Issue
- 9923
- Pages
- 1129-1137
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4171740
- OpenAlex
- W2126115955
- Cited by
- 796
- References
- 28
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 46 · 2023: 42 · 2022: 37 · 2021: 62 · 2020: 68 · 2019: 78 · 2018: 85 · 2017: 109 · 2016: 80 · 2015: 83 · 2014: 51
- FWCI
- 44.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Wellcome Trust (091984)
- Cancer Research UK (11339)
- National Institute for Health and Care Research (NF-SI-0509-10185)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- choroideremia, retinal gene therapy, adeno-associated virus vectors, Rab escort protein 1, CHM gene, X-linked retinal degeneration, visual acuity improvement, retinal sensitivity, microperimetry, retinal detachment, vector dose, rod and cone function, retinal pigment epithelium, eccentric fixation, blindness treatment
- MeSH terms
- Adenoviridae, Adult, Aged, Fluorescence, Genetic Vectors, Humans, Male, Middle Aged, Retinal Detachment, Visual Acuity, Genetic Therapy, Choroideremia, Gene Transfer Techniques, Transgenes, Adaptor Proteins, Signal Transducing, Injections, Intraocular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
